EUVIMEDEUVIMED entdecken
Crossref

Identification of PRTN3 as a novel biomarker for the diagnosis of early gastric cance

Daxin Guo, Biying Zhang, Dong Wu, Xujun Hu, Hanxiao Tu

Journal of Proteomics · 2023

DOI: 10.1016/j.jprot.2023.104852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteomics, 2023. Verfasst von Daxin Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Ningbo No.2 Hospital, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Medical and Health Research Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) remains one of the most common types of cancer worldwide and has a high mortality rate. However, tools for the early detection of gastric cancer are still lacking. Isobaric tagging for relative and absolute quantitation (iTRAQ) proteomic assays were conducted to identify and quantify the differentially expressed proteins (DEPs) in the gastric mucosal tissues of GC patients at different stages. Bioinformatics analysis was used to identify the pathways enriched among the DEPs and candidate marker proteins. The expression levels and distribution of candidate proteins were confirmed by parallel reaction monitoring (PRM) analysis. In this study, by using the iTRAQ quantitative proteomic strategy, we identified 727 and 502 DEPs that were upregulated in EGC vs. PGC and EGC vs. NGC, respectively. These DEPs were mainly involved in the innate immune response and RNA binding. PRTN3 was identified as a marker of early gastric cancer by Gene Ontology enrichment analysis. Furthermore, the PRM assay confirmed the significant overexpression of PRTN3 in EGC gastric mucosa compared to PGC and NGC mucosa. Our data demonstrated that PRTN3 in the gastric mucosa could be used as a novel biomarker to identify patients with early gastric cancer via endoscopy. SIGNIFICANCE: Gastric cancer remains one of the most common types of cancer worldwide and has a high mortality rate. Patients with progressive gastric cancer and gastroesophageal junction cancer have a poor prognosis, with a 5-year relative survival rate of 6%. Therefore, early detection and diagnosis of gastric cancer is a key step toward improving the survival rate. The present study identified PRTN3 as a marker of early gastric cancer by an iTRAQ quantitative proteomic strategy. The PRM assay confirmed the significant overexpression of PRTN3 in EGC gastric mucosa compared to PGC and NGC mucosa. This study discovered that PRTN3 in the gastric mucosa could be used as a novel biomarker to identify patients with early gastric cancer via endoscopy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansBiomarkersGastric MucosaProteomicsMyeloblastin

Stichwörter der Autor:innen

BiomarkerGastric cancerPRTN3iTRAQ

Substanzen

BiomarkersMyeloblastin

Autor:innen und Institutionen

  • Department of Gastroenterology, Ningbo No.2 Hospital, Ningbo, Zhejiang, China.
  • Department of Gastroenterology, Ningbo No.2 Hospital, Ningbo, Zhejiang, China. Electronic address: huxujun@tom.com.
  • Department of Gastroenterology, Ningbo No.2 Hospital, Ningbo, Zhejiang, China. Electronic address: 770319679@qq.com.

Förderung

  • Medical and Health Research Project of Zhejiang Province

Zitieren

APA

Guo, D., Zhang, B., Wu, D., Hu, X., & Tu, H. (2023). Identification of PRTN3 as a novel biomarker for the diagnosis of early gastric cance. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2023.104852

Vancouver

Guo D, Zhang B, Wu D, Hu X, Tu H. Identification of PRTN3 as a novel biomarker for the diagnosis of early gastric cance. Journal of Proteomics. 2023. doi:10.1016/j.jprot.2023.104852

BibTeX
@article{Guo2023,
  author = {Guo, Daxin and Zhang, Biying and Wu, Dong and Hu, Xujun and Tu, Hanxiao},
  title = {Identification of PRTN3 as a novel biomarker for the diagnosis of early gastric cance},
  journal = {Journal of Proteomics},
  year = {2023},
  doi = {10.1016/j.jprot.2023.104852}
}
Kostenlos starten →